FDA Drug Approval Decisions Expected in July 2025
-
To Freeze or Not to Freeze? Discussing Fertility Preservation With Trans FolksAmple fertility preservation options exist for transgender patients — how should health care providers go about discussing these choices?
-
Thyroid Disease and Rheumatic Disease: Is There a Link?We spoke with Clement E Tagoe, MD, PhD, and Daniel G Arkfeld, MD, to discuss the overlap between thyroid disease and rheumatic disease.
-
Measles: What You Need to Know NowThree children have died in the most recent outbreak of measles, to date. This article reviews the signs, symptoms, and treatment of measles, also known as rubeola.
-
How GLP-1s Could Help People Sleep Better — Beyond Weight LossWith the FDA approval of Zepbound (tirzepatide) for obstructive sleep apnea, GLP-1 receptor agonists harbor potential beyond weight and diabetes management.
-
EULAR Updates Guidance for Antirheumatic Drug Use in Reproductive HealthThe EULAR released a 2024 update to the existing guidance on antirheumatic drug use during family planning, pregnancy, breastfeeding, and fertility treatment.
Clinical Tools
Powered by
Powered by 
MORE CLINICAL TOOLS
- Axial Spondyloarthritis
- Connective Tissue Disease
- Crystal Arthropathies
- Diseases of Bone and Cartilage
- General Medicine
- General Rheumatology
- Infection in Rheumatic Disease
- Musculoskeletal Pain
- Myositis
- Osteoarthritis
- Pediatric Rheumatology
- Practice Management
- Psoriatic Arthritis
- Rheumatoid Arthritis
- Sjögren Syndrome
- Systemic Lupus Erythematosus
- Vasculitis